Our guide on semaglutide appetite suppression timeline covers what to expect at each dose level
to 1:00 a.m
Our guide on peptide injection devices covers different administration tools, while understanding what a peptide injection actually involves helps newcomers feel confident about the process
The recent MHRA approval of Wegovy tablets marks an important step forward in obesity treatment, giving patients a licensed oral alternative to weekly injections
Doctors are key in semaglutide safety and monitoring , handling medication interactions with semaglutide , and setting the right dose for each patient
Apr 07, 2026, 08:00 ET Wegovy HD available through 70,000+ US pharmacies, NovoCare Pharmacy, select telehealth providers, and more STEP UP trial data showed average weight loss of ~21% with Wegovy HD at 72 weeks in adults with obesity if all patients stayed on treatment * and ~19% regardless of whether patients stayed on treatment **1 Wegovy HD further expands the offerings for patients within the Wegovy label, inclusive of multiple formulations, including Wegovy pill, and indications not available with other GLP-1 weight loss medicines PLAINSBORO, N.J., April 7, 2026 /PRNewswire/ -- Wegovy HD (semaglutide) injection 7.2 mg is available now nationwide, delivering the highest weight loss of any Wegovy injection to date
